Te Ahumairangi Investment Management Ltd Reduces Holdings in HCA Healthcare, Inc. $HCA

Te Ahumairangi Investment Management Ltd trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 20.6% during the fourth quarter, Holdings Channel reports. The fund owned 10,832 shares of the company’s stock after selling 2,809 shares during the quarter. Te Ahumairangi Investment Management Ltd’s holdings in HCA Healthcare were worth $5,057,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC acquired a new position in HCA Healthcare in the fourth quarter worth about $1,021,000. NewEdge Advisors LLC increased its holdings in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC bought a new stake in HCA Healthcare during the second quarter valued at $2,073,000. Finally, Sei Investments Co. lifted its position in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after buying an additional 49,214 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have issued reports on the stock. JPMorgan Chase & Co. cut their target price on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Weiss Ratings downgraded HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday. Argus dropped their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. KeyCorp reduced their price target on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Finally, UBS Group raised their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research note on Monday, February 23rd. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $506.14.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $377.81 on Friday. The firm has a market cap of $83.81 billion, a P/E ratio of 12.99, a PEG ratio of 1.18 and a beta of 1.12. The stock has a fifty day moving average price of $431.36 and a two-hundred day moving average price of $474.09. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the prior year, the business earned $6.45 EPS. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.